Dashboard
Manage Tickers

PHIO


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
11/03/2025 21:12:06

phio-pharma-secures-134m-through-warrant-exercises-covering-566m-shares-including-reduced-205-pricing-on-465m-shares
Phio Pharma Secures $13.4M Through Warrant...
11/03/2025 19:02:26

Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical-stage siRNA biopharmaceutical company developing therapeutics using its pr...

why-is-phio-pharmaceuticals-stock-soaring-today
Why Is Phio Pharmaceuticals Stock Soaring ...
11/03/2025 18:25:41

Shares of Phio Pharmaceuticals Corp. (NASDAQ: PHIO) are rising Monday after the company provided an update on an ongoing medica...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
11/03/2025 17:05:47

phio-pharma-reports-100-tumor-clearance-in-final-dose-group-of-skin-cancer-trial
Phio Pharma Reports 100% Tumor Clearance I...
11/03/2025 12:49:22

Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its ...

phio-pharma-to-present-update-on-proprietary-intasyl-sirna-technology-and-progress-on-on-going-clinical-trial-with-lead-compound-ph-762-for-treatment-of-skin-cancers
Phio Pharma To Present Update On Proprieta...
09/23/2025 11:50:15

Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its ...

phio-pharma-to-present-ph-762-intasyl-sirna-skin-cancer-trial-progress-and-strategic-outlook-at-life-sciences-future-conference-sept-25-26-2025
Phio Pharma To Present PH-762 INTASYL siRN...
09/18/2025 11:48:35

Key updates to include advances made in the on-going clinical trial for INTASYL siRNA lead product candidate PH-762King of Prus...

phio-pharmaceuticals-to-discuss-strategy-for-ph-762-skin-cancer-drug-at-investor-conference
Phio Pharmaceuticals to Discuss Strategy f...
09/03/2025 11:51:41

Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its propri...

phio-pharmaceuticals-has-been-issued-canadian-patent-number-3027780-titled-reduced-size-self-delivering-rnai-compounds
Phio Pharmaceuticals Has Been Issued Canad...
09/02/2025 19:58:46

https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/3027780/summary.html

hc-wainwright--co-reiterates-buy-on-phio-pharma-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Phio...
08/15/2025 11:17:14

HC Wainwright & Co. analyst Matthew Keller reiterates Phio Pharma (NASDAQ:PHIO) with a Buy and maintains $14 price target.

phio-pharma-q2-eps-045-misses-036-estimate
Phio Pharma Q2 EPS $(0.45) Misses $(0.36) ...
08/14/2025 20:19:55

Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.36)...

phio-pharmaceuticals-announces-25m-in-gross-proceeds-from-exercise-of-928596-warrants-at-200-and-2485-per-share-and-issues-1857192-new-unregistered-warrants-at-2485
Phio Pharmaceuticals Announces $2.5M In Gr...
07/25/2025 19:07:55

Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical-stage siRNA biopharmaceutical company developing therapeutics using its pr...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
07/25/2025 17:07:15

phio-pharmaceuticals-reports-complete-tumor-clearance-in-cscc-patient-and-partial-response-in-stage-4-merkel-cell-carcinoma-in-ongoing-ph-762-phase-1b-trial
Phio Pharmaceuticals Reports Complete Tumo...
07/25/2025 16:40:26

Complete Pathologic Response in patient with cutaneous squamous cell carcinomaPartial Response in Stage 4 metastatic Merkel cel...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
07/25/2025 12:08:49

phio-pharmaceuticals-announces-comprehensive-us-drug-substance-development-services-agreement-for-lead-compound-ph762
Phio Pharmaceuticals Announces Comprehensi...
07/25/2025 11:47:08

hc-wainwright--co-reiterates-buy-on-phio-pharma-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Phio...
06/25/2025 14:43:29

HC Wainwright & Co. analyst Joseph Pantginis reiterates Phio Pharma (NASDAQ:PHIO) with a Buy and maintains $14 price tar...

phio-pharmaceuticals-announced-that-the-safety-monitoring-committee-recommended-dose-escalation-in-its-phase-1b-clinical-trial-of-intratumoral-ph-762-in-the-treatment-of-stages-1-2-and-4-cutaneous-squamous-cell-carcinoma-stage-4-melanoma-and-stage-4-merkel-cell-carcinoma
Phio Pharmaceuticals Announced That The Sa...
06/25/2025 11:49:15

1-phio-pharma-ceo-to-present-new-skin-cancer-data-on-groundbreaking-gene-silencing-therapy-ph-762
1. Phio Pharma CEO To Present New Skin Can...
06/24/2025 11:47:05

Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
06/05/2025 17:06:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION